Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruediger Liersch

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Thrombosis Research|May 4, 2010
Tissue-factor fusion proteins induce occlusion of tumor vesselsChristian Schwöppe, Torsten Kessler, Thorsten Persigehl, et al.
International Journal of Oncology|November 3, 2010
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profileJohannes Dreischalück, Christian Schwöppe, Tilmann Spieker, et al.
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Annals of Hematology|May 1, 2012
POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experienceGabriela B Thoennissen, Nils H Thoennissen, Fleur Fritz, et al.
Cancers|July 2, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor InfarctionAndrew F Berdel, Christian Schwöppe, Caroline Brand, et al.
Blood|April 19, 2012
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patientsRuediger Liersch, Joachim Gerss, Christoph Schliemann, et al.
Journal of Medicinal Chemistry|March 19, 2013
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factorChristian Schwöppe, Caroline Zerbst, Max Fröhlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
S100A2 induces metastasis in non-small cell lung cancerEtmar Bulk, Bülent Sargin, Utz Krug, et al.
International Journal of Cancer|December 13, 2025
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)Thorsten O Goetze, Salah-Eddin Al-Batran, Ruediger Liersch, et al.
The Oncologist|March 29, 2020
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II TrialsGabriele Reinartz, Caroline Molavi Tabrizi, Ruediger Liersch, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Thrombosis Research|May 4, 2010
Tissue-factor fusion proteins induce occlusion of tumor vesselsChristian Schwöppe, Torsten Kessler, Thorsten Persigehl, et al.
International Journal of Oncology|November 3, 2010
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profileJohannes Dreischalück, Christian Schwöppe, Tilmann Spieker, et al.
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Annals of Hematology|May 1, 2012
POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experienceGabriela B Thoennissen, Nils H Thoennissen, Fleur Fritz, et al.
Cancers|July 2, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor InfarctionAndrew F Berdel, Christian Schwöppe, Caroline Brand, et al.
Blood|April 19, 2012
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patientsRuediger Liersch, Joachim Gerss, Christoph Schliemann, et al.
Journal of Medicinal Chemistry|March 19, 2013
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factorChristian Schwöppe, Caroline Zerbst, Max Fröhlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
S100A2 induces metastasis in non-small cell lung cancerEtmar Bulk, Bülent Sargin, Utz Krug, et al.
International Journal of Cancer|December 13, 2025
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)Thorsten O Goetze, Salah-Eddin Al-Batran, Ruediger Liersch, et al.
The Oncologist|March 29, 2020
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II TrialsGabriele Reinartz, Caroline Molavi Tabrizi, Ruediger Liersch, et al.
Pageof 3